Germany’s cost-of-care debate is moving from rhetoric to legislation. And it is landing hard on medicines and hospitals. The latest discussions on German drug price reforms come as Berlin is trying to stabilise statutory health insurance funds that are projected to drift deeper into deficit. Government estimates put the potential shortfall at around €40bn by 2030 if spending is not…
Tag: Germany
-
Global Health must remain a pillar of G7 and G20 agendas
Germany’s Health Minister, Nina Warken, has made an impassioned plea for global health to remain a central pillar of the G7 and G20 agendas, as concerns grow that the United States intends to strip back the G20’s focus to its original financial mandate when it assumes the presidency next year. Speaking to an international audience at the World Health Summit…